Rockfish Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series A
  • (Upcoming)

  • Latest Deal Amount
  • $11.6M

  • Investors
  • 5

Rockfish Bio General Information

Description

Developer of senolytic compound-based therapies intended to treat age-related diseases and disorders. The company specializes in specifically effective methods for eliminating senescent renal epithelial cells with a therapeutic index of up to seven hundred, enabling medical professionals to treat chronic diseases and improve the quality of life by promoting healthy aging.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Leberstrasse 20
  • Vienna, 1110
  • Austria
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Leberstrasse 20
  • Vienna, 1110
  • Austria

Rockfish Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rockfish Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A) $11.6M Upcoming Pre-Clinical Trials
4. Grant 03-Jun-2025 Completed Startup
3. Seed Round 01-Jan-2024 Completed Pre-Clinical Trials
2. Seed Round 17-Nov-2021 $693K $693K Completed Pre-Clinical Trials
1. University Spin-Out 01-Jan-2021 Completed Pre-Clinical Trials
To view Rockfish Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Rockfish Bio Patents

Rockfish Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025242858-A1 Composition for selective elimination of senescent cells Pending 23-May-2024

Rockfish Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rockfish Bio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Rudolf Sallinger Fonds Other
Austria Wirtschaftsservice Venture Capital Minority
red-stars.com data Holding Company Minority
Medical University of Vienna University
University of Natural Resources and Life Sciences, Vienna University
To view Rockfish Bio’s complete investors history, request access »

Rockfish Bio FAQs

  • When was Rockfish Bio founded?

    Rockfish Bio was founded in 2021.

  • Where is Rockfish Bio headquartered?

    Rockfish Bio is headquartered in Vienna, Austria.

  • What is the size of Rockfish Bio?

    Rockfish Bio has 5 total employees.

  • What industry is Rockfish Bio in?

    Rockfish Bio’s primary industry is Drug Discovery.

  • Is Rockfish Bio a private or public company?

    Rockfish Bio is a Private company.

  • What is Rockfish Bio’s current revenue?

    The current revenue for Rockfish Bio is .

  • How much funding has Rockfish Bio raised over time?

    Rockfish Bio has raised $2.66M.

  • Who are Rockfish Bio’s investors?

    Rudolf Sallinger Fonds, Austria Wirtschaftsservice, red-stars.com data, Medical University of Vienna, and University of Natural Resources and Life Sciences, Vienna have invested in Rockfish Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process